Weekly chemotherapy instead of best supportive care alone must be considered for patients of small cell lung cancer with poor performance status.

被引：0
|
作者：
Shrivastav, Gunjan
Gupta, Alok
Sonthwal, Neha
Singla, Suhas Kirti
Mohindra, Tarun
Chaturvedi, Harit Kumar
Rohatgi, Nitesh
机构：
[1] Max Inst Canc Care, Delhi, India
[2] Medanta Mediclin, Lucknow, Uttar Pradesh, India
[3] Max Super Specialty Hosp, Max Inst Canc Care, New Delhi, India
[4] Max Healthcare, New Delhi, India
[5] Max Oncol Daycare Ctr, Delhi, India
[6] Max Superspecialty Hosp, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21102
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
    Li, Hongwei
    Xue, Ruiqi
    Yang, Xiaotang
    Han, Songye
    Yang, Weihua
    Song, Xin
    Zhang, Xiaqin
    Cao, Jianzhong
    Jia, Sufang
    Wang, Weili
    Lian, Jianhong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] COMBINED CHEMOTHERAPY AND RADIOTHERAPY VERSUS BEST SUPPORTIVE CARE IN THE TREATMENT OF INOPERABLE NON-SMALL-CELL LUNG-CANCER
    LEUNG, WT
    SHIU, WCT
    PANG, JCK
    LAU, J
    TAO, M
    LEUNG, SF
    TEO, P
    ONCOLOGY, 1992, 49 (05) : 321 - 326
  • [43] A RANDOMIZED TRIAL OF ALTERNATING CHEMOTHERAPY VERSUS BEST SUPPORTIVE CARE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    CELLERINO, R
    TUMMARELLO, D
    GUIDI, F
    ISIDORI, P
    RASPUGLI, M
    BISCOTTINI, B
    FATATI, G
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) : 1453 - 1461
  • [44] Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status
    Lilenbaum, Rogerio C.
    Huber, Rudolf M.
    Treat, Joseph
    Masters, Gregory
    Kaubitzsch, Sabine
    Lane, Stephen
    Wissel, Paul
    CLINICAL LUNG CANCER, 2006, 8 (02) : 130 - 134
  • [45] Retrospective analysis of the treatment of patients with small cell lung cancer showing poor performance status
    Sakuragi, T
    Oshita, F
    Nagashima, S
    Kasai, T
    Kurata, T
    Fukuda, M
    Yamamoto, N
    Ohe, Y
    Tamura, T
    Eguchi, K
    Shinkai, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (03) : 128 - 133
  • [46] Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status
    Agarwal, Muskan
    Liu, Alex
    Almquist, Daniel
    Langlais, Blake T.
    Leventakos, Konstantinos
    Yu, Nathan Y.
    Manochakian, Rami
    Ernani, Vinicius
    CANCER, 2023, 129 (22) : 3546 - 3553
  • [47] Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status
    Aida, Yuka
    Nakazawa, Kensuke
    Shiozawa, Toshihiro
    Ogawa, Ryoko
    Kiwamoto, Takumi
    Morishima, Yuko
    Sakamoto, Toru
    Sekine, Ikuo
    Hizawa, Nobuyuki
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 613 - 620
  • [48] Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 21 - 25
  • [49] A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer
    Hatzidaki, Dora
    Agelaki, Sofia
    Mavroudis, Dimitris
    Vlachonikolis, Ioannis
    Alegakis, Athanasios
    Georgoulias, Vassilis
    CLINICAL LUNG CANCER, 2006, 8 (01) : 49 - 55
  • [50] Chemotherapy treatment rates and survival in poor performance status small cell lung cancer at a district general hospital
    Reinius, M.
    Rimmer, Y.
    Pulimood, T.
    Patterson, D. M.
    LUNG CANCER, 2016, 91 : S56 - S56
12345